Osobní účet
Osobní účet
Gracell Biotechnologies
Developer of cancer immune therapy designed to treat cancer
Stránky společnostiRok založení
2017
Uzávěrka
2/10/2021
Ziskovost
54.95%
O společnosti
Total Funding
$185M
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives.
Number of employees
51-100
Headquarters
Suzhou, Jiangsu, China